Skip to content

Medical emergency? What to do

Herceptin cancer drug wins final British go-ahead

3-RXPublished August 26, 20062 min read

Key points

  • Britain's cost-effectiveness watchdog issued final guidance on Wednesday recommending that Herceptin should be used in early breast cancer and be paid for by the state health service.
  • NICE had given a preliminary green light to the Roche medicine in June but that decision was challenged by Newbury and Community Primary Care Trust, delaying final approval.
  • Until now, Herceptin has been recommended for treating only metastatic cancer, a late-stage condition in which tumors have spread around the body.
  • It only works in just over one in five breast cancer cases, and it can cause cardiotoxicity, which means it is not suitable for patients with heart problems.

Britain's cost-effectiveness watchdog issued final guidance on Wednesday recommending that Herceptin should be used in early breast cancer and be paid for by the state health service.

The move by the National Institute of Health and Clinical Excellence (NICE) clears the way for the drug to be prescribed on the National Health Service for women with aggressive HER2 breast cancer following surgery.

NICE had given a preliminary green light to the Roche medicine in June but that decision was challenged by Newbury and Community Primary Care Trust, delaying final approval. In the event, the trust's appeal was not upheld.

British authorities have been under intense pressure to back wider use of Herceptin after women with early-stage disease went to court to force local health authorities to pay for it.

Until now, Herceptin has been recommended for treating only metastatic cancer, a late-stage condition in which tumors have spread around the body. The new approval extends its use to a much large number of mainly younger patients.

NICE deliberations are watched closely by other governments, who increasingly have to weigh the benefits of modern medicines against their price. Herceptin costs around 20,000 pounds ($38,000) per patient a year.

Herceptin is not a wonder drug. It only works in just over one in five breast cancer cases, and it can cause cardiotoxicity, which means it is not suitable for patients with heart problems.

But the injectable drug has been shown to prolong survival chances for those women whose tumors contain a large amount of the HER2 protein and NICE Chief Executive Andrew Dillion said it was clearly "clinically and cost effective".

The medicine, which was originally discovered by Roche's U.S. biotech partner Genentech, is the Swiss group's third-biggest product, with sales last year of 2.15 billion Swiss francs ($1.75 billion).

It was first approved in Europe in 2000 and in the United States in 1998 for advanced breast cancer.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.